Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 43

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 43
---
ifel, Nicolaus & Company, Incorporated |     |           |
| Robert W. Baird & Co. Incorporated       |     |           |
| Total                                    |     |           |

Subject to the terms and conditions set forth
in the underwriting agreement, the underwriters have agreed, severally and not jointly, to purchase all of the shares of the Series B
Preferred Stock sold under the underwriting agreement if any of these shares of Series B Preferred Stock are purchased. If an underwriter
defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the
underwriting agreement may be terminated.

The underwriters propose to offer some of the
shares of the Series B Preferred Stock directly to the public at the public offering price set forth on the cover page of this
prospectus supplement and some of the shares of the Series B Preferred Stock to dealers at the public offering price less a concession
not to exceed $ per share. The underwriters may allow, and dealers
may re-allow, a concession not to exceed $ per share on sales
to other dealers. If all of the shares are not sold at the initial offering price, the underwriters may change the public offering price
and the other selling terms.

We have agreed to indemnify the underwriters against
liabilities under the Securities Act or contribute to payments that the underwriters may be required to make in that respect.

Over-Allotment Option

We have granted to the underwriters an option
to purchase up to additional shares of the Series B Preferred Stock within 30 days from the date of this prospectus supplement solely
to cover over-allotments at the public offering price less the underwriting discount. To the extent the option is exercised, each underwriter
must purchase a number of additional shares of the Series B Preferred Stock approximately proportionate to that underwriter’s
initial purchase commitment.

Listing

Prior to the Series B Preferred Stock offering,
there has been no public market for the Series B Preferred Stock. We intend to apply to list the Series B Preferred Stock on
the NYSE under the symbol “GMRE PrB.” If the application is approved, we expect trading of the Series B Preferred Stock
on the NYSE to begin within 30 days after the Series B Preferred Stock is first issued. The underwriters have advised us that they
intend to make a market in the Series B Preferred Stock prior to commencement of any trading on the NYSE. However, the